Transforming the Care of Diabetes and Heart Disease in 2021: The Rise of the SGLT2 Inhibitors - Prevention
Transforming the Care of Diabetes and Heart Disease in 2021: The Rise of the SGLT2 Inhibitors
Enduring Education Activity
Expiration Date: May 2023
1.0 Contact Hours ANCC
Member Price: Free
Non-Member Price: Free
The participant will be able to effectively identify the complications associated with increased mortality related to diabetes including heart failure and CVD, effectively educate on the use of SGLT2, and will self-report knowledge and how to access and incorporate SGLT2's in practice.
Ashlee Whelan, RN
Jonathan D. Rich, MD
Attendees may earn 1.0 contact hours by participating in this activity and completing the evaluation.
Claiming Contact Hours
Attendees can earn one nursing contact hour for every hour of educational time. Learners must complete an evaluation to receive contact hours. The evaluation is available after the activity.
This activity is provided by the American Association of Heart Failure Nurses (AAHFN). The American Association of Heart Failure Nurses (AAHFN) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's (ANCC) Commission on Accreditation.
Disclosure/Conflicts of Interest
The planners and faculty for this activity do not have any relevant relationships to disclose unless listed below. Any resulting conflicts of interest have been resolved according to ANCC guidance.
Disclosure of Commercial Support
AAHFN did not receive commercial support from any organizations for this activity.